Abstract: The invention provides antibody linker drug conjugates wherein antibody is sacituzumab and drug is auristatin analogues or a pharmaceutically acceptable salt thereof. The invention also provides a process of preparing antibody linker conjugates of the present invention.
| # | Name | Date |
|---|---|---|
| 1 | 202517110290-STATEMENT OF UNDERTAKING (FORM 3) [12-11-2025(online)].pdf | 2025-11-12 |
| 3 | 202517110290-Sequence Listing in txt [12-11-2025(online)].txt | 2025-11-12 |
| 4 | 202517110290-Sequence Listing in PDF [12-11-2025(online)].pdf | 2025-11-12 |
| 5 | 202517110290-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [12-11-2025(online)].pdf | 2025-11-12 |
| 6 | 202517110290-FORM 1 [12-11-2025(online)].pdf | 2025-11-12 |
| 7 | 202517110290-DRAWINGS [12-11-2025(online)].pdf | 2025-11-12 |
| 8 | 202517110290-DECLARATION OF INVENTORSHIP (FORM 5) [12-11-2025(online)].pdf | 2025-11-12 |
| 9 | 202517110290-COMPLETE SPECIFICATION [12-11-2025(online)].pdf | 2025-11-12 |
| 10 | 202517110290-FORM 18 [14-11-2025(online)].pdf | 2025-11-14 |
| 11 | 202517110290-Form-4 u-r 138 [17-11-2025(online)].pdf | 2025-11-17 |
| 12 | 202517110290-FORM-26 [02-01-2026(online)].pdf | 2026-01-02 |
| 13 | 202517110290-Proof of Right [09-01-2026(online)].pdf | 2026-01-09 |